Literature DB >> 17870270

[Cholera and pregnancy: epidemiological, clinical, and evolutionary aspects].

S A Diop1, N M Manga, N M Dia, S Gaye, C T Ndour, M Seydi, M Soumare, B M Diop, P S Sow.   

Abstract

OBJECTIVES: This descriptive study had for objective to describe the epidemiological, clinical, therapeutic, and evolutionary aspects of the association cholera and pregnancy during the cholera epidemic in Senegal in 2004 and 2005. MATERIAL AND
METHOD: We analyzed the files of pregnant women admitted in the infectious diseases department of the Fann national University Hospital for suspicion of cholera, from October 11, 2004 to December 31, 2005.
RESULTS: Fifty-two pregnant women were hospitalized and accounted for 1.76% of the patients admitted for cholera in the department. They were an average of 24+/-4.9 years of age and came from the Dakar suburbs in 60% of cases. The source of contagion was food and/or water in 70% of cases. These patients contracted the disease during the summer term of the pregnancy in 31% of cases. Clinically, they presented with a typical choleriform syndrome in 90% of cases, emesis in 100% of cases, and severe dehydration in 27% of cases. The coproculture for 14 women was positive for Vibrio cholerae in 12 cases. For treatment, these patients benefited from intravenous rehydration in 75% of cases and antibiotherapy with doxycyclin 300 mg in unidose. The following complications were noted: 6 abortions, 2 premature childbirths, and a maternal death.
CONCLUSION: The association cholera and pregnancy presents high risks for the fetus and for the mother, requiring a fast and adequate management.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17870270     DOI: 10.1016/j.medmal.2007.05.010

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  9 in total

1.  Cholera in pregnancy: Clinical and immunological aspects.

Authors:  Ashraful I Khan; Fahima Chowdhury; Daniel T Leung; Regina C Larocque; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Int J Infect Dis       Date:  2015-08-14       Impact factor: 3.623

2.  Cholera management and prevention at Hôpital Albert Schweitzer, Haiti.

Authors:  Silvia Ernst; Carolyn Weinrobe; Charbel Bien-Aime; Ian Rawson
Journal:  Emerg Infect Dis       Date:  2011-11       Impact factor: 6.883

Review 3.  Cholera in Pregnancy: A Systematic Review and Meta-Analysis of Fetal, Neonatal, and Maternal Mortality.

Authors:  Nguyen-Toan Tran; Richard Taylor; Annick Antierens; Nelly Staderini
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

4.  Pregnancy Outcomes after a Mass Vaccination Campaign with an Oral Cholera Vaccine in Guinea: A Retrospective Cohort Study.

Authors:  Lise Grout; Isabel Martinez-Pino; Iza Ciglenecki; Sakoba Keita; Alpha Amadou Diallo; Balla Traore; Daloka Delamou; Oumar Toure; Sarala Nicholas; Barbara Rusch; Nelly Staderini; Micaela Serafini; Rebecca F Grais; Francisco J Luquero
Journal:  PLoS Negl Trop Dis       Date:  2015-12-29

5.  Factors Related to Fetal Death in Pregnant Women with Cholera, Haiti, 2011-2014.

Authors:  Erin Schillberg; Cono Ariti; Lindsay Bryson; Rodnie Delva-Senat; Debbie Price; Reynold GrandPierre; Annick Lenglet
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

6.  Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study.

Authors:  Mohammad Ali; Allyson Nelson; Francisco J Luquero; Andrew S Azman; Amanda K Debes; Maurice Mwesawina M'bang'ombe; Linly Seyama; Evans Kachale; Kingsley Zuze; Desire Malichi; Fatima Zulu; Kelias Phiri Msyamboza; Storn Kabuluzi; David A Sack
Journal:  Lancet Infect Dis       Date:  2017-02-02       Impact factor: 25.071

7.  Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh.

Authors:  Ashraful Islam Khan; Mohammad Ali; Fahima Chowdhury; Amit Saha; Iqbal Ansary Khan; Arifuzzaman Khan; Afroza Akter; Muhammad Asaduzzaman; Md Taufiqul Islam; Alamgir Kabir; Young Ae You; Nirod Chandra Saha; Alejandro Cravioto; John D Clemens; Firdausi Qadri
Journal:  Vaccine       Date:  2017-02-11       Impact factor: 3.641

8.  Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy.

Authors:  Ramadhan Hashim; Ahmed M Khatib; Godwin Enwere; Jin Kyung Park; Rita Reyburn; Mohammad Ali; Na Yoon Chang; Deok Ryun Kim; Benedikt Ley; Kamala Thriemer; Anna Lena Lopez; John D Clemens; Jacqueline L Deen; Sunheang Shin; Christian Schaetti; Raymond Hutubessy; Maria Teresa Aguado; Marie Paule Kieny; David Sack; Stephen Obaro; Attiye J Shaame; Said M Ali; Abdul A Saleh; Lorenz von Seidlein; Mohamed S Jiddawi
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24

9.  Cholera in pregnancy: outcomes from a specialized cholera treatment unit for pregnant women in Léogâne, Haiti.

Authors:  Iza Ciglenecki; Mathieu Bichet; Javier Tena; Erneau Mondesir; Mathieu Bastard; Nguyen-Toan Tran; Annick Antierens; Nelly Staderini
Journal:  PLoS Negl Trop Dis       Date:  2013-08-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.